CVS Health Corp - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of CVS Health Corp Company

CVS Health Corporation is a health solutions company. The Company operates in four segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Its Health Care Benefits segment offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services segment provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services, including pharmacy patient care programs, diagnostic testing and vaccination administration.

CVS Health Corp Info



Ticker SymbolCVS

Company nameCVS Health Corp

IPO dateOct 01, 1952

CEOMr. J. David Joyner

Number of employees300000

Security typeOrdinary Share

Fiscal year-endOct 01

AddressOne Cvs Dr.

CityWOONSOCKET

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code02895

Phone14017651500

Websitehttps://cvshealth.com/

Ticker SymbolCVS

IPO dateOct 01, 1952

CEOMr. J. David Joyner

Company Executives of CVS Health Corp



Name

Name/Position

Position

Shareholding

Change

Mr. Larry Robbins

Independent Director

11.95M

--

Mr. Tilak Mandadi

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

47.18K

-21.39%

Mr. Michael F. (Mike) Mahoney

Lead Independent Director

45.91K

+0.31%

Mr. Steven H. Nelson

Executive Vice President and President - Aetna

21.33K

--

Mr. Guy P. Sansone

Independent Director

12.01K

+15.04%

Mr. Douglas H. (Doug) Shulman, J.D.

Independent Director

4.28K

+94.41%

Ms. Leslie V. Norwalk

Director

4.28K

+94.41%

Mr. Roger N. Farah

Executive Chairman of the Board

4.12K

-92.40%

Ms. Alecia A. DeCoudreaux, J.D.

Independent Director

2.97K

--

Dr. Amy L. Compton-Phillips, M.D.

Executive Vice President and Chief Medical Officer

--

Name

Name/Position

Position

Shareholding

Change

Mr. Larry Robbins

Independent Director

11.95M

--

Mr. Tilak Mandadi

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

47.18K

-21.39%

Mr. Michael F. (Mike) Mahoney

Lead Independent Director

45.91K

+0.31%

Mr. Steven H. Nelson

Executive Vice President and President - Aetna

21.33K

--

Mr. Guy P. Sansone

Independent Director

12.01K

+15.04%

Mr. Douglas H. (Doug) Shulman, J.D.

Independent Director

4.28K

+94.41%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

By BusinessUSD

Name

Revenue

Proportion

Pharmacy

55.35B

55.96%

Premiums

34.20B

34.57%

Front Store

5.37B

5.43%

Other

3.52B

3.55%

Net investment income(loss)

487.00M

0.49%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Pharmacy

55.35B

55.96%

Premiums

34.20B

34.57%

Front Store

5.37B

5.43%

Other

3.52B

3.55%

Net investment income(loss)

487.00M

0.49%

Shareholding Stats

Updated: Tue, Aug 19

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

9.44%

Dodge & Cox

5.77%

Capital World Investors

5.28%

BlackRock Institutional Trust Company, N.A.

5.01%

State Street Investment Management (US)

4.63%

Other

69.88%

Shareholders

Proportion

The Vanguard Group, Inc.

9.44%

Dodge & Cox

5.77%

Capital World Investors

5.28%

BlackRock Institutional Trust Company, N.A.

5.01%

State Street Investment Management (US)

4.63%

Other

69.88%

Shareholder Types

Shareholders

Proportion

Investment Advisor

46.35%

Investment Advisor/Hedge Fund

29.75%

Hedge Fund

3.46%

Research Firm

2.64%

Pension Fund

2.06%

Bank and Trust

1.83%

Sovereign Wealth Fund

1.65%

Individual Investor

1.06%

Insurance Company

0.10%

Other

11.10%

Institutional Shareholding



Updated: Wed, Oct 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

3622

1.12B

87.85%

-35.11M

2025Q2

3697

1.12B

88.15%

+11.64M

2025Q1

3787

1.12B

88.80%

+14.13M

2024Q4

3853

1.08B

85.46%

-1.57M

2024Q3

3812

1.05B

83.30%

-34.78M

2024Q2

3834

1.06B

84.02%

-4.44M

2024Q1

3863

1.03B

82.03%

-36.45M

2023Q4

3882

1.05B

81.65%

-1.13M

2023Q3

3770

1.04B

80.61%

-13.78M

2023Q2

3775

1.03B

80.60%

-13.09M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

119.78M

9.44%

+2.04M

+1.74%

Jun 30, 2025

Dodge & Cox

73.29M

5.78%

-170.36K

-0.23%

Jun 30, 2025

Capital World Investors

66.96M

5.28%

-1.44M

-2.10%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

63.56M

5.01%

-1.40M

-2.15%

Jun 30, 2025

State Street Investment Management (US)

58.79M

4.64%

+800.41K

+1.38%

Jun 30, 2025

Fidelity Management & Research Company LLC

37.59M

2.96%

+13.37M

+55.22%

Jun 30, 2025

Geode Capital Management, L.L.C.

28.64M

2.26%

+675.82K

+2.42%

Jun 30, 2025

Capital International Investors

26.39M

2.08%

+202.05K

+0.77%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

19.70M

1.55%

+994.06K

+5.31%

Jun 30, 2025

Pzena Investment Management, LLC

16.75M

1.32%

-935.52K

-5.29%

Jun 30, 2025

Related ETFs



Updated: Sun, Nov 2

Name

Proportion

LSV Disciplined Value ETF

38.5%

iShares U.S. Healthcare Providers ETF

12.05%

Coastal Compass 100 ETF

7.81%

Invesco S&P Ultra Dividend Revenue ETF

6.04%

Davis Select US Equity ETF

5.41%

Simplify Health Care ETF

4.99%

VanEck Retail ETF

4.56%

iShares US Consumer Staples ETF

3.83%

Monarch Volume Factor Dividend Tree Index ETF

3.7%

First Trust Consumer Staples Alphadex Fund

3.53%

LSV Disciplined Value ETF

Proportion38.5%

iShares U.S. Healthcare Providers ETF

Proportion12.05%

Coastal Compass 100 ETF

Proportion7.81%

Invesco S&P Ultra Dividend Revenue ETF

Proportion6.04%

Davis Select US Equity ETF

Proportion5.41%

Simplify Health Care ETF

Proportion4.99%

VanEck Retail ETF

Proportion4.56%

iShares US Consumer Staples ETF

Proportion3.83%

Monarch Volume Factor Dividend Tree Index ETF

Proportion3.7%

First Trust Consumer Staples Alphadex Fund

Proportion3.53%

Dividend



A total of 14.66B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 03, 2025

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025

Jan 23, 2025

Feb 03, 2025

Jan 23, 2025

Sep 19, 2024

CVS.NB Final Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024

Oct 21, 2024

Nov 01, 2024

Oct 21, 2024

Jul 08, 2024

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024

Jul 22, 2024

Aug 01, 2024

Jul 22, 2024

Mar 21, 2024

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024

Apr 22, 2024

May 01, 2024

Apr 19, 2024

Dec 06, 2023

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024

Jan 22, 2024

Feb 01, 2024

Jan 19, 2024

Sep 21, 2023

CVS.NB Final Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 01, 2023

Oct 19, 2023

Jul 07, 2023

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023

Jul 21, 2023

Aug 01, 2023

Jul 20, 2023

Mar 16, 2023

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on May 01, 2023 going ex on Apr 20, 2023

Apr 21, 2023

May 01, 2023

Apr 20, 2023

Dec 15, 2022

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Feb 01, 2023 going ex on Jan 19, 2023

Jan 20, 2023

Feb 01, 2023

Jan 19, 2023

Sep 21, 2022

CVS.NB Final Cash Dividend of gross USD 0.55 paid on Nov 01, 2022 going ex on Oct 20, 2022

Oct 21, 2022

Nov 01, 2022

Oct 20, 2022

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data